Want to see IN:DIVISLAB full AI Analyst Report?
Divi's Laboratories Limited (DIVISLAB) Ratios
Divi's Laboratories Limited Ratios
IN:DIVISLAB's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:DIVISLAB's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.43 | 6.94 | 7.57 | 8.46 | 6.99 |
| Quick Ratio | 3.50 | 4.65 | 5.08 | 5.73 | 4.62 |
| Cash Ratio | 0.06 | 0.30 | 0.28 | 0.15 | 1.02 |
| Solvency Ratio | 0.93 | 1.31 | 1.04 | 1.30 | 1.99 |
| Operating Cash Flow Ratio | 1.48 | 1.34 | 0.99 | 2.23 | 1.60 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 973.00 | 1261.00 | 5018.37 | 2331.46 |
| Net Current Asset Value | $ 78.24B | $ 81.03B | $ 77.76B | $ 76.40B | $ 67.05B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.20 | 1.13 | 1.14 | 1.13 | 1.14 |
| Debt Service Coverage Ratio | 132.78 | 519.00 | 495.00 | 885.11 | 1165.11 |
| Interest Coverage Ratio | 129.48 | 857.00 | 650.67 | 1052.15 | 1795.86 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.13 | 0.26 | 0.23 | 0.24 | 0.21 |
| Net Debt to EBITDA | -0.03 | -0.13 | -0.14 | -0.06 | -0.30 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.20% | 58.50% | 58.07% | 57.91% | 64.86% |
| EBIT Margin | 32.30% | 31.29% | 27.78% | 30.57% | 41.87% |
| EBITDA Margin | 36.69% | 35.60% | 32.62% | 35.02% | 45.42% |
| Operating Profit Margin | 28.20% | 27.57% | 25.04% | 26.61% | 40.61% |
| Pretax Profit Margin | 32.08% | 31.27% | 27.74% | 30.57% | 41.86% |
| Net Profit Margin | 24.32% | 23.50% | 20.52% | 23.54% | 33.64% |
| Continuous Operations Profit Margin | 24.32% | 23.50% | 20.52% | 23.53% | 33.64% |
| Net Income Per EBT | 75.80% | 75.14% | 73.97% | 77.01% | 80.37% |
| EBT Per EBIT | 113.77% | 113.42% | 110.81% | 114.86% | 103.07% |
| Return on Assets (ROA) | 12.82% | 12.93% | 10.34% | 12.63% | 22.13% |
| Return on Equity (ROE) | 15.32% | 14.64% | 11.79% | 14.29% | 25.24% |
| Return on Capital Employed (ROCE) | 16.55% | 16.59% | 13.75% | 15.46% | 29.34% |
| Return on Invested Capital (ROIC) | 12.55% | 12.47% | 10.17% | 11.90% | 23.58% |
| Return on Tangible Assets | 12.82% | 12.93% | 10.35% | 12.64% | 22.15% |
| Earnings Yield | 1.63% | 1.49% | 1.69% | 2.43% | 2.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.40 | 3.13 | 3.61 | 4.32 | 3.63 |
| Payables Turnover | 4.95 | 4.25 | 3.97 | 6.82 | 3.89 |
| Inventory Turnover | 1.52 | 1.16 | 1.03 | 1.73 | 1.09 |
| Fixed Asset Turnover | 1.22 | 1.39 | 1.41 | 1.57 | 1.84 |
| Asset Turnover | 0.53 | 0.55 | 0.50 | 0.54 | 0.66 |
| Working Capital Turnover Ratio | 1.19 | 1.10 | 0.94 | 1.01 | 1.44 |
| Cash Conversion Cycle | 274.42 | 344.15 | 364.54 | 241.79 | 340.64 |
| Days of Sales Outstanding | 107.50 | 116.57 | 101.04 | 84.55 | 100.65 |
| Days of Inventory Outstanding | 240.62 | 313.41 | 355.51 | 210.77 | 333.92 |
| Days of Payables Outstanding | 73.69 | 85.83 | 92.00 | 53.54 | 93.93 |
| Operating Cycle | 348.11 | 429.97 | 456.54 | 295.32 | 434.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 113.67 | 73.30 | 47.50 | 92.63 | 72.02 |
| Free Cash Flow Per Share | 18.72 | 19.14 | 9.72 | 74.81 | 45.15 |
| Dividend Paid and CapEx Coverage Ratio | 0.91 | 0.87 | 0.70 | 1.94 | 1.54 |
| Capital Expenditure Coverage Ratio | 1.20 | 1.35 | 1.26 | 5.20 | 2.68 |
| Operating Cash Flow Coverage Ratio | 431.00 | 486.50 | 420.33 | 547.66 | 518.10 |
| Operating Cash Flow to Sales Ratio | 0.29 | 0.21 | 0.16 | 0.32 | 0.22 |
| Free Cash Flow Yield | 0.31% | 0.34% | 0.27% | 2.65% | 1.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 61.47 | 67.24 | 59.20 | 41.09 | 39.47 |
| Price-to-Sales (P/S) Ratio | 14.95 | 15.80 | 12.15 | 9.67 | 13.28 |
| Price-to-Book (P/B) Ratio | 9.42 | 9.84 | 6.98 | 5.87 | 9.96 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 317.60 | 290.01 | 367.13 | 37.74 | 97.50 |
| Price-to-Operating Cash Flow Ratio | 52.32 | 75.71 | 75.11 | 30.48 | 61.13 |
| Price-to-Earnings Growth (PEG) Ratio | 3.57 | 1.82 | -4.83 | -1.07 | 0.80 |
| Enterprise Value Multiple | 40.71 | 44.25 | 37.11 | 27.56 | 28.93 |
| Enterprise Value | 1.58T | 1.47T | 943.59B | 747.86B | 1.16T |
| EV to EBITDA | 40.71 | 44.25 | 37.11 | 27.56 | 28.93 |
| EV to Sales | 14.94 | 15.75 | 12.10 | 9.65 | 13.14 |
| EV to Free Cash Flow | 317.36 | 289.17 | 365.73 | 37.66 | 96.49 |
| EV to Operating Cash Flow | 52.28 | 75.49 | 74.83 | 30.41 | 60.49 |
| Tangible Book Value Per Share | 631.25 | 563.72 | 511.05 | 480.73 | 441.51 |
| Shareholders’ Equity Per Share | 631.48 | 563.87 | 511.20 | 480.93 | 441.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.25 | 0.26 | 0.23 | 0.20 |
| Revenue Per Share | 397.85 | 351.27 | 293.67 | 291.89 | 331.46 |
| Net Income Per Share | 96.75 | 82.53 | 60.27 | 68.71 | 111.52 |
| Tax Burden | 0.76 | 0.75 | 0.74 | 0.77 | 0.80 |
| Interest Burden | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| SG&A to Revenue | 0.15 | 0.13 | 0.02 | 0.02 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.17 | 0.89 | 0.79 | 1.04 | 0.52 |
Currency in INR
